Viewing nowCombinationDapaensita Tablet 10/100 mg
Dapagliflozin 10mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.

MFDS item code 202301872 · Approved 2023.06.20 · Insurance code 640007910
Improvement of blood glucose control in type 2 diabetes
This medication helps improve blood glucose control more effectively when taken with diet and exercise therapy by patients with type 2 diabetes. Dapagliflozin and sitagliptin act together to stabilize blood glucose levels and are used for the treatment of individuals who have difficulty managing their blood glucose levels.
This medication can be administered at a dosage of 1 tablet per day without regard to meals for patients taking sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole.
This medication is used for the treatment of diabetes, and caution is required during administration. First, allergic reactions may occur while taking this medication, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, you should stop taking it immediately and consult a doctor. In addition, serious inflammation of the pancreas known as pancreatitis may rarely occur, so if you experience abdominal pain, vomiting, or persistent abdominal discomfort, you should notify medical personnel immediately. This medication should not be used in patients with severely impaired kidney function or those on dialysis, and dosage adjustments may be necessary for patients with mildly impaired kidney function. It is important to evaluate fluid volume status and kidney function before use, and particularly elderly patients or those on diuretics should be closely monitored for signs of dehydration or hypotension. Because this medication has a blood glucose-lowering effect, there may be an increased risk of hypoglycemia when taken with other blood glucose-lowering agents, such as insulin or sulfonylureas, and dosage adjustments may be necessary. Weight loss may occur, and there is a possibility of genital infections or urinary tract infections, so appropriate treatment should be sought if related symptoms appear. Pregnant or breastfeeding women are advised not to use this medication, and if planning to become pregnant or if pregnancy is confirmed, discontinuation is recommended. The safety and efficacy of this medication have not been established in children under 18 years, and it should not be used in this age group. In cases of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms, and some may be removed through hemodialysis. While taking this medication, there may be risks associated with driving or operating machinery due to symptoms of hypoglycemia, so caution is advised. Finally, this medication should be kept out of the reach of children and stored in its original container to maintain quality.
Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain of the mucous membranes in the mouth/eyes, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, significantly reduced urine output, severe swelling with increased blood pressure, anaphylaxis,
Vulvovaginitis, balanitis, urinary tract infection, fungal infection, hypoglycemia, thirst, dizziness, constipation, dry mouth, lumbar pain, dysuria, polyuria, nocturia, vulvar itching, genital itching, increased hematocrit, decreased initial kidney creatinine clearance, dyslipidemia, increased blood creatinine, increased blood urea, weight loss, upper respiratory infection, nasopharyngitis, headache, diarrhea, dyspepsia, nausea, vomiting, vaginal discharge, and
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air or moisture, and it is safe to store at room temperature between 1 to 30 degrees Celsius. Maintaining appropriate temperature and container conditions can prolong the effectiveness of the medication.
Light yellow round film-coated tablet
30 tablets - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin 10mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationSitagliptin Phosphate Hydrate 128.5mg · Dapagliflozin 10mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.